Abgent Overview

  • Founded
  • 2001
  • Status
  • Acquired/​Merged
  • Employees
  • 51
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Abgent General Information


Developer of primary antibodies. The company primarily provides biological research reagent products such as antibodies, peptides and protein as well as cellular pharmacology, bio-marker discovery, clinical development services.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • 9765 Clairemont Mesa Boulevard
  • Suite C
  • San Diego, CA 92124
  • United States
+1 (888) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Abgent Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Abgent‘s full profile, request access.

Request a free trial

Abgent Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of primary antibodies. The company primarily provides biological research reagent products such as antibodies,
Other Pharmaceuticals and Biotechnology
San Diego, CA
51 As of 2015

00000 00

agna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex e
00000 000000000000000 000 0000000000000
Littleton, CO
00 As of 0000
00.00 0000-00-00


trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
00000 000000000000000 000 0000000000000
Hillsborough, NJ
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Abgent Competitors (23)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novus Biologicals Formerly PE-Backed Littleton, CO 00 000000&0
00000000, 000 Corporation Hillsborough, NJ
0000000 Corporation Houston, TX
0000000 Angel-Backed Irvine, CA 00 00000 000000000 - 00000
000 0000000000000 Corporate Backed or Acquired Woburn, MA 000000&0
You’re viewing 5 of 23 competitors. Get the full list »

Abgent Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial